RYR2 and catecholaminergic polymorphic ventricular tachycardia: Most RyR2 mutations that trigger CPVT, including H2464D, are gain-of-function mutations implying greater Ca2+ release and/or increased intracellular [Ca2+], which may lead to increased contractility where there are no associated compensatory mechanisms.